Fundz

Bighat Biosciences Completes Its Acquisition Of Frugi Biotechnology

PRIVATEMar 28, 2022

Acquiring Company

BigHat Biosciences

Acquired Company

Frugi Biotechnology

San MateoBiotechnologyOther

Description

BigHat Biosciences, Inc., a biotechnology company developing safer, more effective next-generation antibody therapies for patients using machine learning and synthetic biology, today announced the acquisition of Frugi Biotechnology, a biotechnology company developing cost-effective and high-quality cell-free protein synthesis (CFPS) technology. The terms of the transaction were not disclosed.

Who to call at BigHat Biosciences, and when

When BigHat Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day BigHat Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BigHat Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BigHat Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BigHat Biosciences

Location

1900 ALAMEDA DE LAS PULGAS

San Mateo, California, United States

About

BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BigHat Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Peyton
Senior decision-maker at this company
••••••••@••••••••

See Peyton's verified email →

Brett
Senior decision-maker at this company
••••••••@••••••••

See Brett's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for BigHat Biosciences's next move

Learn about Strategic plan

Frequently asked

Who acquired Frugi Biotechnology?

Frugi Biotechnology was acquired by BigHat Biosciences, based in San Mateo. The deal was reported on March 28, 2022. BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. BigHat Biosciences is privately held and operates in Biotechnology.

When did BigHat Biosciences acquire Frugi Biotechnology?

BigHat Biosciences's acquisition of Frugi Biotechnology was reported on March 28, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Frugi Biotechnology do?

Frugi Biotechnology makes a cost-effective and reliable expression system available for cell free protein applications. The methods are derived from a RAPID NSF PFI project spun out of Iowa State University. Frugi operates out of a facility in Ames, Iowa. It is privately held, operating in Other.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.